Nuvectis Pharma, Inc. (NVCT) income statement
NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$19.39−0.45 (-2.27%)
Close on Nov 20, 2026Market cap $631.76MP/E –Yield 0.00%
Nuvectis Pharma, Inc. financial ratios
See a number that looks wrong?